The rally in the global markets was triggered by an unexpected slowdown in the US Manufacturing PMI, which gave hope that the US Fed would slow the pace of policy tightening. Following suit, US bond yields fell in tandem with the US dollar.
Drug companies in pink of health, further upside expected
Nifty’s Pharma and Healthcare indices have gained 1.7% and 2.6% respectively in the past month, while the benchmark Nifty declined 2% in this period.